Production (Stage)
Merck KGaA
MKGAF
$134.20
$4.403.39%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.03B | 3.01B | 2.93B | 2.84B | 2.95B |
| Total Depreciation and Amortization | 1.86B | 1.86B | 1.86B | 1.84B | 1.83B |
| Total Amortization of Deferred Charges | 117.26M | 117.26M | 111.96M | 111.96M | 111.96M |
| Total Other Non-Cash Items | 337.31M | 312.81M | 255.33M | 177.90M | -175.31M |
| Change in Net Operating Assets | -917.50M | -329.53M | -363.71M | -417.99M | -426.33M |
| Cash from Operations | 4.43B | 4.97B | 4.79B | 4.55B | 4.30B |
| Capital Expenditure | -1.79B | -1.84B | -1.96B | -1.92B | -1.91B |
| Sale of Property, Plant, and Equipment | 22.98M | 29.66M | 39.26M | 23.83M | 20.64M |
| Cash Acquisitions | -843.57M | -843.57M | -612.28M | -13.03M | -13.03M |
| Divestitures | 1.07M | 7.58M | 6.51M | 6.51M | 6.51M |
| Other Investing Activities | -406.36M | -671.32M | -606.70M | 259.80M | 429.74M |
| Cash from Investing | -3.01B | -3.32B | -3.13B | -1.65B | -1.46B |
| Total Debt Issued | 2.83B | 2.83B | 1.99B | 1.26B | 1.22B |
| Total Debt Repaid | -4.42B | -2.91B | -1.76B | -1.96B | -2.06B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.10B | -1.11B | -1.11B | -1.11B | -1.21B |
| Other Financing Activities | 127.00M | 127.00M | 89.00M | -10.00M | -10.00M |
| Cash from Financing | -2.61B | -1.03B | -752.98M | -1.88B | -2.12B |
| Foreign Exchange rate Adjustments | -57.47M | -17.55M | -33.66M | -18.30M | -18.36M |
| Miscellaneous Cash Flow Adjustments | 1.09M | 2.17M | 2.19M | -2.50K | 1.07M |
| Net Change in Cash | -1.25B | 595.69M | 869.84M | 1.00B | 696.11M |